Patient | Age (Years) | Clinical stage | Pathological stage | Histology | Margin | Adjuvant chemotherapy | Survival years |
Patient X | 32 | G2cT2N0M0 | G2pT2N0M0 | Transitional carcinoma | Negative | Gemcitabine-cisplastin | 5 |
Patient Y | 47 | G3cT3N1Mx | G3PT3N1Mx | Transitional carcinoma | Negative | Gemcitabine-cisplastin | 1 |
Patient Z | 62 | G2cT2N0M0 | G1pT2N1M0 | Transitional carcinoma | Negative | G2 | 1 |
Patient M | 62 | G3cT2N0M0 | G3pT2N0M0 | Transitional carcinoma with epidermoid differentiation | Negative | Gemcitabine-cisplastin | 1 |
Patient B | 74 | G3cT2N1M0 | G2pT3N1M0 | Transitional carcinoma | Negative | Gemcitabine-cisplastin | 4 |